A case of pulmonary tuberculosis complicated with an orthotopic liver transplantation

Kekkaku

Volumn 81, Issue 4, 2006, Pages 351-355

  Kamiya, Hiroyuki ^a   Toyota, Emiko ^a   Kobayashi, Nobuyuki ^a   Kudo, Koichiro ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Desensitization therapy; Drug interaction; Liver damage; Orthotopic liver transplantation; Pulmonary tuberculosis; Tacrolimus

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ARTICLE; CASE REPORT; HUMAN; LIVER TRANSPLANTATION; LUNG TUBERCULOSIS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATION;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; TACROLIMUS; TUBERCULOSIS, PULMONARY;

EID: 33746536766     PISSN: 00229776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Paterson DL, Singh N, Gayowski T, et al.: Pulmonary nodules in liver transplantation recipients. Medicine. 1998; 77: 50-58.
2. Japanese source
3. Singh N: Infectious complications in organ transplant recipients with the use of calcineurin-inhibitor agent-based immunosuppressive regiments. Current Opinion in Infectious Diseases. 2005; 18: 342-345.
4. Aguado JM, Herrero JA, Gavalda J, et al.: Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Transplantation. 1997; 63: 1278-1286.
5. Singh N, Paterson DL: Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infectious Dis. 1998; 27: 1266-1277.
6. Grauhan O, Lohmann R, Lemmens P, et al.: Mycobacterial infection after liver transplantation. Langenbecks Arch Chir. 1995; 380: 171-175.
7. Meyers BR, Halpern M, Sheiner P, et al.: Tuberculosis in liver transplant patients. Transplantation. 1994; 58: 301-306.
8. Kiuchi T, Tanaka K, Inomata S, et al.: Experience of Tacrolimus-Based Immunosuppression in Living-Related Liver Transplantation Complicated With Graft Tuberculosis: Interaction With Rifampicin and Side Effects. Transplantation Proc. 1996; 28: 3171-3172.
9. Nishizaki T, Yanaga K, Soejima Y, et al.: Tuberculosis following liver transplantation: report of a case and review of the literature. Transpl Int. 1996; 9: 589-592.
10. Akamatsu N, Sugawara Y, Nakajima J, et al.: Resection of a Pulmonary Lesion After Liver Transplantation: Report of a Case. Surg Today. 2005; 35: 976-978.
11. Japanese source
12. Japanese source
13. Japanese source
14. Japanese source
15. Japanese source
16. Cisneros JT, Caston JJ, Moreno J, et al.: Tuberculosis in the transplant candidate: importance of early diagnosis and treatment. Transplantation. 2004; 77: 1376-1380.
17. Graham JC, Kearns AM, Magee JG, et al.: Tuberculosis, transmitted through transplantation. J Infect. 2001; 43: 251-254.
18. Japanese source
19. Singh N, Wagener MM, Gayowski T, et al.: Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidancy for the prevention of posttransplant tuberculosis. Transplantation. 2002; 74: 892-895.
20. Meyers BR, Papanicolaou GA, Sheiner P, et al.: Tuberculosis in orthotopic liver transplant patients: increased toxicity of recommended agents; cure of disseminated infection with nonconventional regimens. Transplantation. 2000; 69: 64-69.
21. Benito N, Sued O, Moreno A, et al.: Diagnosis and treatment of latent tuberculosis infection in liver transplant recipients in an endemic area. Transplantation. 2002; 74: 1381-1386.
22. Chaparro SV, Montoya JG, Keeffe EB, et al.: Risk of tuberculosis in tuberculin skin test-positive liver transplant patients. Clin Infectious Dis. 1999; 29: 207-208.